New hope for tough breast cancer: drug combo trial launches
NCT ID NCT07376629
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called HB0025 combined with chemotherapy (nab-paclitaxel) as a first treatment for people with advanced triple-negative breast cancer that cannot be removed by surgery. The goal is to see if the combination is safe and works better than chemotherapy alone. About 60 adults who have not had prior treatment for metastatic disease will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TNBC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Hospital of Jining Medical University
Jining, China
-
Anhui Provincial Hospital
Hefei, China
-
Anyang Cancer Hospital
Anyang, China
-
Fudan University Shanghai Cancer Center
Shanghai, China
-
Fujian Cancer Hospital
Fujian, China
-
Guangdong Provincial People's Hospital
Guangdong, China
-
Harbin Medical University Cancer Hospital
Harbin, China
-
Jiangsu Province Hospital
Nanjing, China
-
Liaoning Cancer Hospital
Shengyang, China
-
Linyi Cancer Hospital
Linyi, China
-
Shandong Cancer Hospital
Shandong, China
-
Shanxi Cancer Hospital
Shanxi, China
-
Sichuan Cancer Hospital
Chengdu, China
-
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Hangzhou, China
-
Sun Yat-sen University Cancer Center
Guangzhou, China
-
The First Affiliated Hospital of Xiamen University
Xiamen, China
-
The First Hospital of Jilin University
Jilin City, China
-
The Second Affiliated Hospital of Soochow University
Suzhou, China
-
The Second Affiliated Hospital of Xi'an Jiaotong University
Xi'an, China
-
Tianjin Cancer Hospital
Tianjing, China
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, China
-
Xiangya Hospital Central South University
Changsha, China
-
Xuzhou Central Hospital
Xuzhou, China